Media

Merrimack Pharmaceuticals is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. Merrimack applies Network Biology, its proprietary systems biology-based approach to biomedical research, throughout the research and development process. Merrimack currently has six oncology therapeutics in clinical development. 

 

Contacts

 

Kathleen Petrozzelli Gallagher

Merrimack Pharmaceuticals

617-441-1043

kgallagher@merrimackpharma.com

 

Liz Bryan

Spectrum

202-955-6222

lbryan@spectrumscience.com